Morphea
☆ I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
Ko te mate o Morphea te nuinga o te wa ka puta mai he papawai atrophic.
References
Ko te Scleroderma he mate onge e pa ana ki nga kopa honohono, ka kitea he kiri whakapakeke, a, i etahi wa ka pa ki etahi atu wahanga o te tinana. E rua nga momo matua: systemic sclerosis , e pa ana ki te whakapakeke o te kiri me nga whekau o roto, me te localized scleroderma , e kiia ana ko te morphea, ka noho iti ki te kiri me nga kopa kei raro iho, me te akoranga ngawari me te whakaiti i a ia ano. Ahakoa he tauhou te scleroderma o te rohe me te kore e marama ana te take, ko nga rangahau o naianei e kii ana ka pa ki nga whekau o roto ka pa atu ki nga momo take hauora. He mea tino nui te maimoatanga moata ki te aukati i nga raruraru, i te mea ko te taumahatanga pea o te localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Ko te Morphea , e mohiotia ana ko te scleroderma rohe, he mate autoimmune onge e pa ana ki te kiko hono. Ka puta mai i roto i nga huarahi rereke, a ehara i te mea tino noa, me te ahua 0. 4 - 2. 7 mo ia 100,000 tangata ia tau. Ka kitea te Morphea ki nga tamariki kei waenga i te 2 ki te 14 tau, a he maha ake te pa ki nga kotiro i nga tama tane.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Ko Morphea he mate onge. Na te hanganga o te whakaahua, i pohehe pea te algorithm mo te morphea.